Advanced search
Publication Cover
Clinical Toxicology Volume 53, 2015 - Issue 3
Submit an article Journal homepage
579
Views
27
CrossRef citations to date
0
Altmetric
Critical Care

Comparison of intermittent and continuous extracorporeal treatments for the enhanced elimination of dabigatran

Josée BouchardDepartment of Nephrology, Hôpital du Sacré-Coeur de Montréal, University of Montreal, Montreal, Canada
,
Marc GhannoumDepartment of Nephrology, Verdun Hospital, University of Montreal, Montreal, Canada
,
Amélie Bernier-JeanDepartment of Nephrology, Hôpital du Sacré-Coeur de Montréal, University of Montreal, Montreal, Canada
,
David WilliamsonDepartment of Pharmacy, Hôpital du Sacré-Coeur de Montréal, University of Montreal, Montreal, Canada
,
Geoffrey KershawDepartment of Haematology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
,
Claire WeatherburnDepartment of Haematology, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
,
Josette M. ErisDepartment of Renal Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia
,
Huyen TranDepartment of Clinical Haematology, The Alfred Hospital, Melbourne, Australia;Australian Centre for Blood Diseases, Monash University, Clayton, Australia
,
Jignesh P. PatelDepartment of Haematological Medicine, Kings College Hospital NHS Foundation Trust, Denmark Hill, London, UK
&
Darren M. RobertsDepartment of Renal Medicine, Royal Prince Alfred Hospital, Camperdown, New South Wales, Australia;Drug Health Services, Royal Prince Alfred Hospital, Missenden Road, Camperdown, Sydney, Australia;Burns, Trauma and Critical Care Research Centre, School of Medicine, Royal Brisbane and Women's Hospital, Butterfield Street, Herston, Queensland, AustraliaCorrespondence[email protected]
 show all
Pages 156-163 | Received 22 Oct 2014, Accepted 02 Jan 2015, Published online: 08 Feb 2015

Citations (27)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (4)

Akshay Athavale, Nazila Jamshidi & Darren M. Roberts. (2020) Incomplete responses to the recommended dose of idarucizumab: a systematic review and pharmacokinetic analysis. Clinical Toxicology 58:8, pages 789-800.
Read now
Verena Gotta, Kim Dao, Frédérique Rodieux, Thierry Buclin, Françoise Livio & Marc Pfister. (2017) Guidance to develop individual dose recommendations for patients on chronic hemodialysis. Expert Review of Clinical Pharmacology 10:7, pages 737-752.
Read now
William E. Dager & Linda Banares. (2017) Reversing the anticoagulation effects of dabigatran. Hospital Practice 45:2, pages 29-38.
Read now
Josh J. Wang, Eric Villeneuve & Sophie Gosselin. (2017) Letter in response to “Idarucizumab for dabigatran overdose”. Clinical Toxicology 55:1, pages 65-65.
Read now

Articles from other publishers (23)

Francis Flynn, Guillaume Richard, Marc A. Dobrescu, Josée Bouchard, David Williamson, Dave Brindamour, Emmanuel Charbonney & Sébastien Dupuis. (2020) Refractory Dabigatran-Induced Hemorrhage Despite Multiple Idarucizumab Administration and Renal Replacement Therapy. Journal of Pharmacy Practice 35:2, pages 302-307.
Crossref
Bruno Mégarbane, Mathieu Oberlin, Jean-Claude Alvarez, Frederic Balen, Sébastien Beaune, Régis Bédry, Anthony Chauvin, Isabelle Claudet, Vincent Danel, Guillaume Debaty, Arnaud Delahaye, Nicolas Deye, Jean-Michel Gaulier, Francis Grossenbacher, Philippe Hantson, Frédéric Jacobs, Karim Jaffal, Magali Labadie, Laurence Labat, Jérôme Langrand, Frédéric Lapostolle, Philippe Le Conte, Maxime Maignan, Patrick Nisse, Philippe Sauder, Christine Tournoud, Dominique Vodovar, Sebastian Voicu, Pierre-Géraud Claret & Charles Cerf. (2020) Management of pharmaceutical and recreational drug poisoning. Annals of Intensive Care 10:1.
Crossref
Parth Rali, Andrew Gangemi, Aimee Moores, Kerry Mohrien & Lisa Moores. (2019) Direct-Acting Oral Anticoagulants in Critically Ill Patients. Chest 156:3, pages 604-618.
Crossref
Melissa A. NestorBryan Boling. (2019) Reversing Direct Oral Anticoagulants in Acute Intracranial Hemorrhage. Critical Care Nurse 39:3, pages e1-e8.
Crossref
Stephy George, Margarita Taburyanskaya & Vicky Lewis. (2019) Probable drug–drug interaction between dabigatran and quinidine resulting in thrombin time rebound despite multiple idarucizumab doses. Blood Coagulation & Fibrinolysis 30:1, pages 42-46.
Crossref
Thomas Gremmel, Alexander Niessner, Hans Domanovits, Martin Frossard, Gürkan Sengölge, Barbara Steinlechner, Thomas Sycha, Michael Wolzt & Ingrid Pabinger. (2018) Non-vitamin K antagonist oral anticoagulants in patients with an increased risk of bleeding. Wiener klinische Wochenschrift 130:23-24, pages 722-734.
Crossref
Marc Ghannoum, Robert S. Hoffman, Sophie Gosselin, Thomas D. Nolin, Valery Lavergne & Darren M. Roberts. (2018) Use of extracorporeal treatments in the management of poisonings. Kidney International 94:4, pages 682-688.
Crossref
Nicholas Farina & James T. Miller. (2018) Pharmacologic Reversal of Direct Oral Anticoagulants. Critical Care Nursing Quarterly 41:2, pages 121-128.
Crossref
Mariagrazia Porru, Antonella Mameli, Maria E. Cianchetti, Mario Musu, Paola Schirru, Maria F. Ruberto, Doris Barcellona & Francesco Marongiu. (2016) Dabigatran overdose: a case report of acute hepatitis. Extracorporeal treatment. International Journal of Hematology 105:4, pages 532-535.
Crossref
Ashley ThompsonFanny LiA. Kendall Gross. (2017) Considerations for Medication Management and Anticoagulation During Continuous Renal Replacement Therapy. AACN Advanced Critical Care 28:1, pages 51-63.
Crossref
Edelgard Lindhoff-Last. (2017) Direct oral anticoagulants (DOAC) – Management of emergency situations. Hämostaseologie 37:04, pages 257-266.
Crossref
Bethany T. Samuelson & Adam Cuker. (2017) Measurement and reversal of the direct oral anticoagulants. Blood Reviews 31:1, pages 77-84.
Crossref
Monique J. Cormier & Marc Ghannoum. 2017. Critical Care Toxicology. Critical Care Toxicology 267 278 .
William Dager & Thaddaus Hellwig. (2016) Current knowledge on assessing the effects of and managing bleeding and urgent procedures with direct oral anticoagulants. American Journal of Health-System Pharmacy 73:10_Supplement_2, pages s14-s26.
Crossref
Karl-Heinz Liesenfeld, Fredrik Gruenenfelder & Andreas Clemens. (2016) Enhanced elimination of dabigatran: Identifying the appropriate patient for the use of continuous venovenous hemodialysis instead of intermittent hemodialysis-A simulation analysis. The Journal of Clinical Pharmacology 56:5, pages 597-608.
Crossref
Sara E. Parli, Melissa L. Thompson Bastin & Daniel A. Lewis. (2016) Use of Continuous Renal Replacement Therapy for Removal of Dabigatran in a Patient in Need of Emergent Surgery. Case Reports in Critical Care 2016, pages 1-5.
Crossref
Aibek E. Mirrakhimov, Aram Barbaryan, Adam Gray & Taha Ayach. (2016) The Role of Renal Replacement Therapy in the Management of Pharmacologic Poisonings. International Journal of Nephrology 2016, pages 1-12.
Crossref
Kevin K. Chung & Ian J. Stewart. 2016. Principles of Adult Surgical Critical Care. Principles of Adult Surgical Critical Care 159 168 .
Monique J. Cormier & Marc Ghannoum. 2016. Critical Care Toxicology. Critical Care Toxicology 1 12 .
C. Chai‐Adisaksopha, C. Hillis, W. Lim, K. Boonyawat, K. Moffat & M. Crowther. (2015) Hemodialysis for the treatment of dabigatran‐associated bleeding: a case report and systematic review. Journal of Thrombosis and Haemostasis 13:10, pages 1790-1798.
Crossref
Christopher Beynon, Oliver W. Sakowitz, Dominic Störzinger, Berk Orakcioglu, Alexander Radbruch, Anna Potzy & Andreas W. Unterberg. (2015) Intracranial haemorrhage in patients treated with direct oral anticoagulants. Thrombosis Research 136:3, pages 560-565.
Crossref
Tanja A Treschan & Martin Beiderlinden. (2015) Antidotes for anticoagulants: a long way to go. The Lancet 386:9994, pages 634-636.
Crossref
Kathryn J. Lang, Prakash Saha, Lara N. Roberts & Roopen Arya. (2015) Changing paradigms in the management of deep vein thrombosis. British Journal of Haematology 170:2, pages 162-174.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.